Wilms' tumor gene 1 (WT1) in endometrial carcinoma
Authors:
- An CoosemansACAn Coosemans
- Philippe MoermanPMPhilippe Moerman
- Godelieve VerbistGVGodelieve Verbist
- Wim MaesWMWim Maes
- Patrick NevenPNPatrick Neven
- Ignace VergoteIVIgnace Vergote
- Stefaan W. Van GoolSGStefaan W. Van Gool
- Frédéric AmantFAFrédéric Amant
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 111 (3) , 502-508
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1New England Journal of Medicine, 2008
- The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivoOncogene, 2008
- Upregulation of Wilms’ tumour gene 1 (WT1) in uterine sarcomasEuropean Journal of Cancer, 2007
- Immunohistochemical detection of WT1 protein in a variety of cancer cellsLaboratory Investigation, 2006
- Antigen-specific cellular immunotherapy of leukemiaLeukemia, 2005
- Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarrayGynecologic Oncology, 2004
- The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomesHuman Molecular Genetics, 2003
- Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicityLeukemia, 2003
- Analysis of the wilms tumor suppressor gene WT1 in endometrial carcinomaGenes, Chromosomes and Cancer, 1995
- WT-1 is required for early kidney developmentCell, 1993